1. Home
  2. FBIOP vs RIBB Comparison

FBIOP vs RIBB Comparison

Compare FBIOP & RIBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • RIBB
  • Stock Information
  • Founded
  • FBIOP N/A
  • RIBB 2024
  • Country
  • FBIOP United States
  • RIBB Japan
  • Employees
  • FBIOP 186
  • RIBB N/A
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • RIBB
  • Sector
  • FBIOP Health Care
  • RIBB
  • Exchange
  • FBIOP Nasdaq
  • RIBB NYSE
  • Market Cap
  • FBIOP N/A
  • RIBB N/A
  • IPO Year
  • FBIOP N/A
  • RIBB 2025
  • Fundamental
  • Price
  • FBIOP $5.75
  • RIBB $10.04
  • Analyst Decision
  • FBIOP
  • RIBB
  • Analyst Count
  • FBIOP 0
  • RIBB 0
  • Target Price
  • FBIOP N/A
  • RIBB N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • RIBB 85.0K
  • Earning Date
  • FBIOP N/A
  • RIBB 01-01-0001
  • Dividend Yield
  • FBIOP N/A
  • RIBB N/A
  • EPS Growth
  • FBIOP N/A
  • RIBB N/A
  • EPS
  • FBIOP N/A
  • RIBB N/A
  • Revenue
  • FBIOP N/A
  • RIBB N/A
  • Revenue This Year
  • FBIOP N/A
  • RIBB N/A
  • Revenue Next Year
  • FBIOP N/A
  • RIBB N/A
  • P/E Ratio
  • FBIOP N/A
  • RIBB N/A
  • Revenue Growth
  • FBIOP N/A
  • RIBB N/A
  • 52 Week Low
  • FBIOP N/A
  • RIBB $9.95
  • 52 Week High
  • FBIOP N/A
  • RIBB $10.04
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 35.47
  • RIBB N/A
  • Support Level
  • FBIOP $5.50
  • RIBB N/A
  • Resistance Level
  • FBIOP $6.74
  • RIBB N/A
  • Average True Range (ATR)
  • FBIOP 0.27
  • RIBB 0.00
  • MACD
  • FBIOP -0.08
  • RIBB 0.00
  • Stochastic Oscillator
  • FBIOP 20.00
  • RIBB 0.00

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Share on Social Networks: